Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Mina

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
The Journal of Infection|June 26, 2017
Generalized herd effects and vaccine evaluation: impact of live influenza vaccine on off-target bacterial colonisationMichael J Mina
The Journal of Infection|June 26, 2017
Measles, immune suppression and vaccination: direct and indirect nonspecific vaccine benefitsMichael J Mina
The Lancet. Respiratory Medicine|October 5, 2019
Passive immunity for the treatment of influenza: quality not quantitySanjat Kanjilal, Michael J Mina
Mbio|May 15, 2014
Reply to "no clinical association of live attenuated influenza vaccine with nasal carriage of bacteria or acute otitis media": specific recommendations for future studiesMichael J Mina, Keith P Klugman
Science (New York, N.Y.)|January 8, 2021
COVID-19 testing: One size does not fit allMichael J Mina, Kristian G Andersen
The Lancet. Respiratory Medicine|August 19, 2014
The role of influenza in the severity and transmission of respiratory bacterial diseaseMichael J Mina, Keith P Klugman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2020
To Interpret the SARS-CoV-2 Test, Consider the Cycle Threshold ValueMichael R Tom, Michael J Mina
Infection and Immunity|January 16, 2013
Pathogen replication, host inflammation, and disease in the upper respiratory tractMichael J Mina, Keith P Klugman
Nature Medicine|April 29, 2020
Antibody testing will enhance the power and accuracy of COVID-19-prevention trialsMarc Lipsitch, Rebecca Kahn, Michael J Mina
European Journal of Epidemiology|November 3, 2019
Measles vaccine immune escape: Should we be concerned?Luojun Yang, Bryan T Grenfell, Michael J Mina
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
The Journal of Infection|June 26, 2017
Generalized herd effects and vaccine evaluation: impact of live influenza vaccine on off-target bacterial colonisationMichael J Mina
The Journal of Infection|June 26, 2017
Measles, immune suppression and vaccination: direct and indirect nonspecific vaccine benefitsMichael J Mina
The Lancet. Respiratory Medicine|October 5, 2019
Passive immunity for the treatment of influenza: quality not quantitySanjat Kanjilal, Michael J Mina
Mbio|May 15, 2014
Reply to "no clinical association of live attenuated influenza vaccine with nasal carriage of bacteria or acute otitis media": specific recommendations for future studiesMichael J Mina, Keith P Klugman
Science (New York, N.Y.)|January 8, 2021
COVID-19 testing: One size does not fit allMichael J Mina, Kristian G Andersen
The Lancet. Respiratory Medicine|August 19, 2014
The role of influenza in the severity and transmission of respiratory bacterial diseaseMichael J Mina, Keith P Klugman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2020
To Interpret the SARS-CoV-2 Test, Consider the Cycle Threshold ValueMichael R Tom, Michael J Mina
Infection and Immunity|January 16, 2013
Pathogen replication, host inflammation, and disease in the upper respiratory tractMichael J Mina, Keith P Klugman
Nature Medicine|April 29, 2020
Antibody testing will enhance the power and accuracy of COVID-19-prevention trialsMarc Lipsitch, Rebecca Kahn, Michael J Mina
European Journal of Epidemiology|November 3, 2019
Measles vaccine immune escape: Should we be concerned?Luojun Yang, Bryan T Grenfell, Michael J Mina
Pageof 7